MGC Pharmaceuticals Ltd. announced the following changes to the Board. Mr. Daniel Robinson has been appointed as a Non-Executive Director of the Company effective immediately. Mr. Robinson has over 20 years' experience in a broad range of corporate roles across stockbroking, corporate advisory, investor relations and governance.

He is an experienced Company Secretary and Director of both private and listed companies. Additionally, Mr. Robinson is a Member of the Australian Institute of Company Directors. Dr. Stephen Parker and Dr. Ross Walker will be stepping down from the Board to pursue other opportunities.